Glixx Laboratories Inc
Your exclusive source for bioactive molecules
Chemical Name: GSK2140944; GSK-2140944; (3R)-3-[[4-(3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione
Purity: >98% (HPLC)
Novel, first-in-class triazaacenaphthylene antibiotic, selectively inhibits type IIA topoisomerases through a unique mechanism that is not utilized by any currently approved human therapeutic agent, interacting with the bacterial subunits of DNA gyrase (GyrA) and topoisomerase IV (ParC) and against Gram-positive acute bacterial skin and skin structure infections (ABSSSIs)
Place an order!